ENDRA Life Sciences (NDRA) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for ENDRA Life Sciences
Is ENDRA Life Sciences a buy right now? The alternative data says hold. This NDRA stock analysis is built on the 25+ alternative data signals AltIndex tracks on ENDRA Life Sciences every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 46/100: a Hold. The stock trades at $5.83 with a $9M market cap.
The soft spots over the past 90 days: headcount (according to LinkedIn) down 10.5% to 17 employees. The rest of the signal set is holding steady, which keeps NDRA at a hold rather than a sell.
NDRA’s broader alt-data profile also covers web traffic (1K monthly visits), X followers (580), and sentiment (100/100). Every signal links to its own page with full history, the NDRA technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on NDRA is just below.
ENDRA Life Sciences AI Stock Analysis
ENDRA Life Sciences is a company that operates in the medical device sector, focusing on innovative ultrasound technology to assist clinics and hospitals worldwide. Their flagship product, the Thermo Acoustic Enhanced Ultrasound (TAEUS) system, seeks to broaden and enhance traditional ultrasound applications, particularly in the non-invasive assessment of liver fat.
Analysis generated September 1, 2026.
Recent ENDRA Life Sciences Stock Alerts
|
ENDRA Life Sciences | September 4 Price is up by 7% in the last 24h. |
|
ENDRA Life Sciences | September 3 Price is down by -7.1% in the last 24h. |
|
ENDRA Life Sciences | September 2 Price is up by 11.2% in the last 24h. |
|
ENDRA Life Sciences | September 1 Price is up by 6.9% in the last 24h. |
ENDRA Life Sciences Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 1K | N/A | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 17 | 10.5% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 5 | N/A | |
| Stocktwits Mentions | 7 | 250.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 11K | 0.8% | |
| X Followers | 580 | 0.9% |
About ENDRA Life Sciences (NDRA)
ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company is headquartered in Ann Arbor, Michigan.
| Price | $5.83 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $9M |
| Year Range | $3 – $8 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Health Care Services |
Latest ENDRA Life Sciences News
View more →
Halper Sadeh LLC is Investigating Whether BOLD and NDRA are Obtaining Fair Deals for their ShareholdersJuly 2 - GlobeNewswire |
|
 |
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--FSRL, SYNA, TECH, and NDRAJuly 2 - PRNewswire |
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement FinancingJune 25 - GlobeNewswire |
|
 |
ASP Isotopes Nears Helium Production, Advances Stable Isotope GrowthAugust 21 - MarketBeat |
ASP Isotopes Inc. Announces that Renergen Limited’s Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South AfricaAugust 6 - GlobeNewswire |
See ENDRA Life Sciences’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for NDRA, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEENDRA Life Sciences Earnings & Financial Performance
View all earnings →ENDRA Life Sciences Insider Trading Activity
View all →| UBS Group AG filed to sell 146,012 shares at $0.0. Aug 27 '24 |
| UBS Group AG filed to sell 146,012 shares at $0.0. Aug 27 '24 |
ENDRA Life Sciences Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to ENDRA Life Sciences
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
bioAffinity TechnologiesBIAF |
$10.50 17.6% | $9M | 54 |
 |
Check-CapMBAI |
$6.42 0.9% | $9M | 46 |
 |
XWELLXWEL |
$0.93 2.8% | $8M | 46 |
 |
Hong Kong Pharma DigitalHKPD |
$0.13 0.3% | $6M | 48 |
 |
Inspire Veterinary PartnersIVP |
$0.03 16.1% | $4M | 48 |
Explore ENDRA Life Sciences Data
Frequently Asked Questions: ENDRA Life Sciences (NDRA)
ENDRA Life Sciences has an AltIndex AI Score of 46/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
46/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of ENDRA Life Sciences (NDRA) stock is $5.83 with a market cap of $9M.
As of today, ENDRA Life Sciences’s PE (Price to Earnings) ratio is —.
View the latest ENDRA Life Sciences insider transactions to see recent buying and selling activity by company executives and directors.
Check the ENDRA Life Sciences congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The NDRA stock price chart above shows ENDRA Life Sciences’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full ENDRA Life Sciences technical analysis for RSI, moving averages, and more.
See the stocks similar to ENDRA Life Sciences section on this page for companies in the same industry ranked by market cap and AI Score.
